May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Identification of ABCA4 Regulatory Mutations in Stargart Families
Author Affiliations & Notes
  • C.M. Zaremba
    Molecular & Human Genetics, Baylor College Medicine, Houston, TX
  • W. Wiszniewski
    Molecular & Human Genetics, Baylor College Medicine, Houston, TX
  • R.A. Lewis
    Molecular & Human Genetics, Baylor College Medicine, Houston, TX
    Ophthalmology,
    Baylor College of Medicine, Baylor College of Medicine, TX
  • J.R. Lupski
    Molecular & Human Genetics, Baylor College Medicine, Houston, TX
    Pediatrics,
    Baylor College of Medicine, Baylor College of Medicine, TX
  • Footnotes
    Commercial Relationships  C.M. Zaremba, None; W. Wiszniewski, None; R.A. Lewis, None; J.R. Lupski, None.
  • Footnotes
    Support  NIH Grant EY13255
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1794. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.M. Zaremba, W. Wiszniewski, R.A. Lewis, J.R. Lupski; Identification of ABCA4 Regulatory Mutations in Stargart Families . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1794.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Stargart disease (STGD1) is an autosomal recessive retinal dystrophy characterized by progessive atrophy of the central retina and RPE, accumulation of drusen in the mid–peripheral RPE, sequential atrophy of the optic disc, and a dark choroids sign on fluorescein angiography. Current studies, in addition to direct sequencing, have begun screening for ABCA4 mutant alleles using a microarray–based assay focused specifically on the coding region, leaving a substantial fraction of mutant alleles unaccounted for. These methods, while effective, limit the ability to detect all possible mutations. Therefore, the purpose of this study is to identify potential regulatory mutations found in the non–coding regions of ABCA4. Methods: Using a commercially available microarray, ABCR–400, we screened a cohort of 192 families with STGD. Families were then subjected to haplotype analysis using markers spanning the ABCA4 genomic region: D1S435, D1S2868, D1S2793, and D1S206. Additionally, a ∼2 kb segment upstream of the 5’ UTR was analyzed for mutations in predicted regulatory regions. Results: We identified two distinct groups of families possessing zero (16 families; 8.33%) or one (40 families; 20.8%) coding region alteration in ABCA4. Preliminary data regarding segregation analysis demonstrated that in 7 out of 16 (43.8%) families bearing no ABCA4 alterations, STGD patients shared the same haplotypes at the disease locus. Conclusions: These data suggest that a substantial fraction of mutations are undetected in patients with STGD. We conclude that the majority of these mutations may reside in the non–coding region of ABCA4 or potentially at other loci.

Keywords: retinal degenerations: hereditary • retina • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×